161 related articles for article (PubMed ID: 7473442)
1. Efficacy of oral micronized progesterone in the treatment of luteal phase defects.
Frishman GN; Klock SC; Luciano AA; Nulsen JC
J Reprod Med; 1995 Jul; 40(7):521-4. PubMed ID: 7473442
[TBL] [Abstract][Full Text] [Related]
2. Effect of oral administration of dydrogestrone versus vaginal administration of natural micronized progesterone on the secretory transformation of endometrium and luteal endocrine profile in patients with premature ovarian failure: a proof of concept.
Fatemi HM; Bourgain C; Donoso P; Blockeel C; Papanikolaou EG; Popovic-Todorovic B; Devroey P
Hum Reprod; 2007 May; 22(5):1260-3. PubMed ID: 17227809
[TBL] [Abstract][Full Text] [Related]
3. Comparison of oral dydrogestrone with progesterone gel and micronized progesterone for luteal support in 1,373 women undergoing in vitro fertilization: a randomized clinical study.
Ganesh A; Chakravorty N; Mukherjee R; Goswami S; Chaudhury K; Chakravarty B
Fertil Steril; 2011 May; 95(6):1961-5. PubMed ID: 21333984
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support.
Simunic V; Tomic V; Tomic J; Nizic D
Fertil Steril; 2007 Jan; 87(1):83-7. PubMed ID: 17081536
[TBL] [Abstract][Full Text] [Related]
5. Oral micronized progesterone combined with vaginal progesterone gel for luteal support.
Tomic V; Tomic J; Klaic DZ
Gynecol Endocrinol; 2011 Dec; 27(12):1010-3. PubMed ID: 21504340
[TBL] [Abstract][Full Text] [Related]
6. [Luteal phase support after vaginal progesterone: comparative study with micronized oral progesterone].
Pouly JL; Bassil S; Frydman R; Hédon B; Nicollet B; Prada Y; Antoine JM; Zambrano R; Donnez J
Contracept Fertil Sex; 1997; 25(7-8):596-601. PubMed ID: 9410372
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of vaginal progesterone capsules (Utrogest 200) compared with progesterone gel (Crinone 8%) for luteal phase support during assisted reproduction.
Kleinstein J;
Fertil Steril; 2005 Jun; 83(6):1641-9. PubMed ID: 15950631
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of oral micronized progesterone when applied via vaginal route.
Choavaratana R; Manoch D
J Med Assoc Thai; 2004 May; 87(5):455-8. PubMed ID: 15222511
[TBL] [Abstract][Full Text] [Related]
9. Disturbances of the endometrium in the luteal phase of cycles stimulated for in vitro fertilization and of normal cycles treated with vaginal progesterone.
Kresanov I; Nikkanen V; Klemi P
Ann Chir Gynaecol Suppl; 1994; 208():33-9. PubMed ID: 8092768
[TBL] [Abstract][Full Text] [Related]
10. Uses of progesterone in clinical practice.
Warren MP; Shantha S
Int J Fertil Womens Med; 1999; 44(2):96-103. PubMed ID: 10338267
[TBL] [Abstract][Full Text] [Related]
11. Elevation of serum progesterone with oral micronized progesterone after in vitro fertilization. A randomized, controlled trial.
Colwell KA; Tummon IS
J Reprod Med; 1991 Mar; 36(3):170-2. PubMed ID: 2030491
[TBL] [Abstract][Full Text] [Related]
12. Prospective, randomized study to evaluate the success rates using hCG, vaginal progesterone or a combination of both for luteal phase support.
Ludwig M; Finas A; Katalinic A; Strik D; Kowalcek I; Schwartz P; Felberbaum R; Küpker W; Schöpper B; Al-Hasani S; Diedrich K
Acta Obstet Gynecol Scand; 2001 Jun; 80(6):574-82. PubMed ID: 11380297
[TBL] [Abstract][Full Text] [Related]
13. Estradiol/progesterone substitution in the luteal phase improves pregnancy rates in stimulated cycles--but only in younger women.
Gleicher N; Brown T; Dudkiewicz A; Karande V; Rao R; Balin M; Campbell D; Pratt D
Early Pregnancy (Cherry Hill); 2000 Jan; 4(1):64-73. PubMed ID: 11719823
[TBL] [Abstract][Full Text] [Related]
14. Luteal phase support using micronized vaginal progesterone as pessaries or capsules in artificial cycles: is there any difference?
Labarta E; Rodríguez-Varela C; Salvaleda-Mateu M; Kohls G; Bosch E
Reprod Biomed Online; 2024 May; 48(5):103638. PubMed ID: 38484430
[TBL] [Abstract][Full Text] [Related]
15. Effects of early luteal-phase vaginal progesterone supplementation on the outcome of in vitro fertilization and embryo transfer.
Mui Lam P; Chun Cheung M; Ping Cheung L; Ingrid Lok H; John Haines C
Gynecol Endocrinol; 2008 Dec; 24(12):674-80. PubMed ID: 19172535
[TBL] [Abstract][Full Text] [Related]
16. Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial.
Tomic V; Tomic J; Klaic DZ; Kasum M; Kuna K
Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():49-53. PubMed ID: 25622239
[TBL] [Abstract][Full Text] [Related]
17. Luteal phase deficiency and infertility: difficulties encountered in diagnosis and treatment.
Annos T; Thompson IE; Taymor ML
Obstet Gynecol; 1980 Jun; 55(6):705-10. PubMed ID: 7383457
[TBL] [Abstract][Full Text] [Related]
18. Oral progestogen versus intramuscular progesterone for luteal support after assisted reproductive technology treatment: a prospective randomized study.
Iwase A; Ando H; Toda S; Ishimatsu S; Harata T; Kurotsuchi S; Shimomura Y; Goto M; Kikkawa F
Arch Gynecol Obstet; 2008 Apr; 277(4):319-24. PubMed ID: 17938943
[TBL] [Abstract][Full Text] [Related]
19. Progesterone administration in patients with absent ovaries.
Devroey P; Palermo G; Bourgain C; Van Waesberghe L; Smitz J; Van Steirteghem AC
Int J Fertil; 1989; 34(3):188-93. PubMed ID: 2567713
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone.
Zarutskie PW; Phillips JA
Fertil Steril; 2009 Jul; 92(1):163-9. PubMed ID: 19362303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
